Sodium Iodide → HCID 21701300, compound
Reaction equation
[H-].[Na+].[CH3:3][CH:4]([CH3:29])[CH2:5][C:6]1[C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][C:11]=2[NH:10][C:9](=[O:17])[CH:8]([NH:18][C:19]([NH:21][C:22]2[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[CH:23]=2)=[O:20])[N:7]=1.[I-].[Na+].Cl[CH2:33][C:34]1[C:39]([CH3:40])=[CH:38][CH:37]=[CH:36][N:35]=1>CN(C)C=O>[CH3:3][CH:4]([CH3:29])[CH2:5][C:6]1[C:12]2[CH:13]=[CH:14][CH:15]=[CH:16][C:11]=2[N:10]([CH2:33][C:34]2[C:39]([CH3:40])=[CH:38][CH:37]=[CH:36][N:35]=2)[C:9](=[O:17])[CH:8]([NH:18][C:19]([NH:21][C:22]2[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[CH:23]=2)=[O:20])[N:7]=1Participants
Procedure
To a suspension of sodium hydride (0.027 g of a 64% dispersion in mineral oil) in N,N-dimethylformamide (3 ml) was added gradually N-[(3RS)-2,3-dihydro-5-(2-methylpropyl)-2-oxo-1H-1,4-benzodiazepin-3-yl]-N′-(3-methylphenyl)urea (0.200 g) at ambient temperature and the mixture was stirred for 1 hour under the same conditions. To the mixture was added sodium iodide (0.107 g) and followed dropwise a solution of 2-chloromethyl-3-methylpridine (0.093 g,) in N,N-dimethylformamide (2 ml) at the same temperature. The resultant mixture was concentrated in vacuo and the residue was taken up with ethyl acetate and water. The aqueous layer was extracted with another ethyl acetate. The combined organic layer was dried over sodium sulfate, filtered and concentrated in vacuo to give a crude compound. The crude compound was recrystallized with isopropyl ether and chloroform to give N-[(3RS)-2,3-dihydro-5-(2-methylpropyl)-1-(3-methylpyridin-2-yl)methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-N′-(3-methylphenyl)urea (0.23 g) as a colorless powder.
Workup
- concentrationThe resultant mixture was concentrated in vacuo
- extractionThe aqueous layer was extracted with another ethyl acetate
- dry with materialThe combined organic layer was dried over sodium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- customto give a crude compound
- customThe crude compound was recrystallized with isopropyl ether and chloroform
Sources & evidence
- ORD record
- ord-8c7363c3b8f740abaea465bc2c626608
- Source dataset
- uspto-grants-2001_09
- Patent number
- US06291452B1
Reaction notes
Loading…